PDL Bioharma Biotech Manufacturing Facility, Brooklyn Park, Minnesota, USA
Key Data:
Order year
2002
Project type
New biologics manufacturing facility (Phase 1)
Location
Brooklyn Park, Minnesota, USA
Estimated investment
$200m
Completion
Structural 2004, validation 2006–2007
Output chemicals
Humanised monoclonal antibodies
Key Players:
Sponsor
Protein Design Laboratories Inc
Designer
Fluor Corporation, Dell Comm
Contractors
Fluor Corporation, Dell Comm, Ortronics, Berk-Tek
Financing
Protein Design Laboratories Inc
